CD44 and breast carcinoma: In this study, we showed that in two breast cancer cell lines – MDA-MB-231 and MCF-7 – subpopulations with the CD44+/CD24- surface marker phenotype have increased miR-10b expression relative to their parental cell line or other subpopulations.